pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    cocaine hydrochloride
    Numbrino (cocaine hydrochloride)
    Local Anesthetic Effect Cody Laboratories Inc
  • Preclinical
    colesevelam
    COLESEVELAM (colesevelam [INN])
    Diarrhea Viscera Labs Inc
  • Marketed
    colesevelam hydrochloride
    Colesevelam Hydrochloride
    Heterozygous Familial Hypercholesterolemia (heFH) Nivagen Pharmaceuticals Inc
  • Marketed
← prev
page 167 of 231
next →
131
Pain89
Neurology1
colestipol hydrochloride
Colestipol Hydrochloride
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)
Carnegie Pharmaceuticals LLC
  • Marketed
    colistimethate sodium
    Colistimethate Sodium
    Lower Respiratory Tract Infections Xellia Pharmaceuticals USA LLC
  • Marketed
    collagenase clostridium histolyticum
    Xiaflex (collagenase clostridium histolyticum)
    Peyronies Disease Auxilium Pharmaceuticals LLC
  • Phase 2
    comekibart
    comekibart [INN]
    Atopic Dermatitis (Atopic Eczema) Shanghai Mabgeek Biotechnology Co Ltd
  • Phase 1
    comtifator
    comtifator
    Alzheimer's Disease Bristol-Myers Squibb Co
  • Marketed
    concizumab
    Alhemo (concizumab)
    Hemophilia A (Factor VIII Deficiency) Novo Nordisk Inc
  • Marketed
    conestat alfa
    Ruconest (conestat alfa [INN])
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN… Pharming Healthcare, Inc.
  • Marketed
    conivaptan hydrochloride
    Vaprisol (conivaptan hydrochloride)
    Hyponatremia$CPIX CUMBERLAND PHARMACEUTICALS INC
  • Marketed
    conjugated estrogens
    Conjugated Estrogens
    Hypoestrogenism Ingenus Pharmaceuticals LLC
  • Phase 3
    contezolid
    contezolid
    Diabetic Foot Infection (DFI) MicuRx Pharmaceuticals Inc
  • Phase 3
    contezolid acefosamil
    contezolid acefosamil
    Diabetic Foot Infection (DFI) MicuRx Pharmaceuticals Inc
  • Marketed
    copanlisib hydrochloride
    Aliqopa (copanlisib hydrochloride)
    Follicular Lymphoma Bayer HealthCare Pharmaceuticals Inc
  • Phase 3
    coramitug
    coramitug
    Amyloid Cardiomyopathy Novo Nordisk AS
  • Phase 2
    corticorelin
    corticorelin [INN]
    Peritumoral Brain Edema Curatis AG
  • Marketed
    corticotropin
    Acthar (corticotropin [INN])
    Membranous Glomerulonephritis Cerium Pharmaceuticals Inc
  • Phase 3
    crenolanib besylate
    crenolanib besylate
    Refractory Acute Myeloid Leukemia Arog Pharmaceuticals Inc
  • Phase 3
    cretostimogene grenadenorepvec
    cretostimogene grenadenorepvec
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$CGON CG Oncology, Inc.
  • Marketed
    crinecerfont
    Crenessity (crinecerfont)
    Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)$NBIX NEUROCRINE BIOSCIENCES INC
  • Marketed
    crisaborole
    Eucrisa (crisaborole)
    Atopic Dermatitis (Atopic Eczema)$PFE PFIZER INC
  • Phase 1
    crisdesalazine
    crisdesalazine [INN]
    Amyotrophic Lateral Sclerosis GNT Pharma Co Ltd
  • Marketed
    crizanlizumab
    Adakveo (crizanlizumab-tmca)
    Sickle Cell Disease$NVS NOVARTIS AG
  • Marketed
    crizotinib
    Xalkori (crizotinib)
    Anaplastic Large Cell Lymphoma (ALCL)$PFE PFIZER INC
  • Marketed
    crofelemer DR
    Mytesi (crofelemer)
    Chemotherapy-Induced Diarrhea (CID) Napo Pharmaceuticals Inc
  • Marketed
    crotamiton
    Crotan (crotamiton [INN])
    Pruritus Marnel Pharmaceuticals LLC
  • Phase 3
    crovalimab
    Piasky (crovalimab-akkz)
    Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associa… F. Hoffmann-La Roche Ltd
  • Phase 1
    curcumin
    Sickle Cell Disease Vascarta Inc
  • Phase 2
    cusatuzumab
    cusatuzumab [INN]
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) OncoVerity Inc